Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

JANXJANX
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in JANUX THERAPEUTICS INC

BANK OF AMERICA CORP /DE/ holds 910,460 shares of JANX (JANUX THERAPEUTICS INC), worth $14M as of 2026-Q2. The position was increased (+13.6% shares). JANX represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$14M

Current Shares

910,460

Total Value Change

-$28.6M

Total Shares Change

+115,699

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
910,460
+13.6%
$14M0.0%$15.36
32
2026-Q1
Increased
801,646
+8.6%
$11.1M0.0%$13.44
30
2025-Q4
Increased
738,330
+49.6%
$10.2M0.0%$13.83
38
2025-Q3
Decreased
493,452
-42.6%
$12.1M0.0%$23.70
0
2025-Q2
Increased
859,423
+14.7%
$19.9M0.0%$23.15
32
2025-Q1
Decreased
749,326
-5.7%
$20.2M0.0%$29.10
0
2024-Q4
New
794,761
-
$42.6M0.0%$52.50
40

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used